James A. Schoeneck
James A. Schoeneck's purchase track record
How the stock did after each of James A. Schoeneck's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/21/2025 | CLDI | $150K | -18.8% | -56.9% | +7.7% |
| 6/30/2025 | KYNB | $119K | +132.4% | +65.7% | +11.3% |
| 3/20/2025 | KYNB | $105K | -31.8% | +35.1% | +17.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
Kyntra Bio Names Andrew Singer to Board. Kyntra Bio has added Andrew E. Singer, MBA, to its board of directors. The move expands the company’s leadership team and could bring new expertise to its strategic planning. The appointment follows the company’s ongoing efforts to strengthen governance and support its growth initiatives. Investors may view the change as a sign of continued focus on development and operational improvement.
Transaction History
| CLDI | ▲ Buy | Open Market | 75,000 | $150K | 8/21/2025 | View on chart |
| KYNB | ▲ Buy | Open Market | 23,567 | $119K | 6/30/2025 | View on chart |
| KYNB | ▲ Buy | Open Market | 50,000 | $17K | 3/21/2025 | View on chart |
| KYNB | ▲ Buy | Open Market | 250,000 | $88K | 3/20/2025 | View on chart |
| CLDI | ▲ Buy | Grant | 79,687 | — | 6/28/2024 | View on chart |
| CLDI | ▲ Buy | Option Exercise | 173,000 | $35K | 6/3/2024 | View on chart |
| CLDI | ▲ Buy | Option Exercise | 375,000 | $75K | 6/3/2024 | View on chart |
| CLDI | ▲ Buy | Grant | 375,000 | $150K | 4/18/2024 | View on chart |
| CLDI | ▲ Buy | Grant | 28,207 | — | 3/29/2024 | View on chart |
| CLDI | ▲ Buy | Grant | 10,625 | $19K | 12/21/2023 | View on chart |
| KYNB | ▼ Sell | Open Market | 7,100 | $128K | 6/7/2023 | View on chart |
| KYNB | ▲ Buy | Grant | 8,289 | $0 | 6/7/2023 | View on chart |
| KYNB | ▲ Buy | Grant | 15,777 | $0 | 6/16/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
CLDI Included in After-Market Movers List
Calidi Biotherapeutics was listed among 12 health care stocks moving in Tuesday's after-market session. The stock is currently trading near its 52-week low of $1.03, reflecting significant volatility. This inclusion highlights recent price action in the biotech sector.
CLDI Included in After-Market Movers List. Calidi Biotherapeutics was listed among 12 health care stocks moving in Tuesday's after-market session. The stock is currently trading near its 52-week low of $1.03, reflecting significant volatility. This inclusion highlights recent price action in the biotech sector.